Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus

Phytomedicine

Volumn 16, Issue 9, 2009, Pages 856-863

  Kim, Kwanghee ^a   Kim, Hyunyul ^a   Kwon, Jeunghak ^a   Lee, Sungwon ^a   Kong, Hyunseok ^a   Im, Sun A ^b   Lee, Young Hee ^b   Lee, Young Ran ^b   Oh, Sun Tack ^b   Jo, Tae Hyung ^c   Park, Young In ^d   Lee, Chong Kil ^b   Kim, Kyungjae ^a  

^a Sahmyook University   (South Korea)

^b Chungbuk National University   (South Korea)

^c Univera Inc   (South Korea)

^d Korea University   (South Korea)

Author keywords

Adipocyte; Aloe vera gel; Antidiabetic activity; Diet induced obesity; Insulin sensitivity; Type 2 diabetes

Indexed keywords

ALOE VERA EXTRACT; GLUCOSE; PIOGLITAZONE; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; EPIDIDYMIS FAT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LIPID DIET; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; SYMPTOM; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOCYTES; ADIPOSE TISSUE; ALOE; ANIMALS; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET; DISEASE MODELS, ANIMAL; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MICE; MICE, INBRED C57BL; OBESITY; PHYTOTHERAPY; PLANT PREPARATIONS; TRIGLYCERIDES;

ALOE VERA; MUS;

EID: 67650568107     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.02.014     Document Type: Article

References (30)

1. Agarwal O.P. Prevention of atheromatous heart disease. Angiology 36 (1985) 485-492
2. Ajabnoor M.A. Effect of aloes on blood glucose levels in normal and alloxan diabetic mice. J. Ethnopharmacol. 28 (1990) 215-220
3. Beppu H., Nagamura Y., and Fujita K. Hypoglycaemic and antidiabetic effects in mice of Aloe arborescens Miller var. natalensis Berger. Phytother. Res. 7 (1993) S37-S42
4. Beppu H., Shimpo K., Chihara T., Kaneko T., Tamai I., Yamaji S., Ozaki S., Kuzuya H., and Sonoda S. Antidiabetic effects of dietary administration of Aloe arborescens Miller components on multiple low-dose streptozotocin-induced diabetes in mice: investigation on hypoglycemic action and systemic absorption dynamics of aloe components. J. Ethnopharmacol. 103 (2006) 468-477
5. Bunyapraphatsara N., Yongchaiyudha S., Rungpitarangsi V., and Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice. II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine 3 (1996) 245-248
6. Coleman D.L. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14 (1978) 141-148
7. DeFronzo R.A., Bonadonna R.C., and Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15 (1992) 318-368
8. Ghannam N., Kingston M., Al-Meshaal I.A., Tariq M., Parman N.S., and Woodhouse N. The antidiabetic activity of aloes: preliminary clinical and experimental observations. Horm. Res. 24 (1986) 288-294
9. Hikino H., Takahashi M., Murakami M., Konno C., and Mirin Y. Isolation and hypoglycemic activity of Arborans A and B, glycans of Aloe arborescens var. natalensis leaves. Int. J. Crude Drug Res. 24 (1986) 183-186
10. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
11. Koo M.W.L. Aloe vera: antiulcer and antidiabetic effects. Phytother. Res. 8 (1994) 461-464
12. Kuhn C.M., Cochrane C., Feinglos M.N., and Surwit R.S. Exaggerated peripheral responses to catecholamines contributes to stress-induced hyperglycemia in the ob/ob mouse. Pharmacol. Biochem. Behav. 26 (1987) 491-495
13. Manco M., Bertuzzi A., Salinari S., Scarfone A., Calvani M., Greco A.V., and Mingrone G. The ingestion of saturated fatty acid triacylglycerols acutely affects insulin secretion and insulin sensitivity in human subjects. Br. J. Nutr. 92 (2004) 895-903
14. Manco M., Calvani M., and Mingrone G. Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes. Metab. 6 (2004) 402-413
15. Marcovecchio M., Mohn A., and Chiarelli F. Type 2 diabetes mellitus in children and adolescents. J. Endocrinol. Invest. 28 (2005) 853-863
16. Mills E., Kuhn C.M., Feinglos M.N., and Surwit R. Hypertension in CB57BL/6J mouse model of non-insulin-dependent diabetes mellitus. Am. J. Physiol. 264 (1993) R73-R78
17. Portha B., Blondel O., Serradas P., McEvoy R., Giroix M.H., Kergoat M., and Bailbe D. The rat models of non-insulin dependent diabetes induced by neonatal streptozotocin. Diabetes Metab. 15 (1989) 61-75
18. Qiu Z., Jones K., Wylie M., Jia Q., and Orndorff S. Modified Aloe barbadensis polysaccharide with immunoregulatory activity. Planta Med. 66 (2000) 152-156
19. Rajasekaran S., Sivagnanam K., Ravi K., and Subramanian S. Hypoglycemic effect of Aloe vera gel on streptozotocin-induced diabetes in experimental rats. J. Med. Food 7 (2004) 61-66
20. Rajasekaran S., Sivagnanam K., and Subramanian S. Modulatory effects of Aloe vera leaf gel extract on oxidative stress in rats treated with streptozotocin. J. Pharm. Pharmacol. 57 (2005) 241-246
21. Rajasekaran S., Ravi K., Sivagnanam K., and Subramanian S. Beneficial effects of aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes. Clin. Exp. Pharmacol. Physiol. 33 (2006) 232-237
22. Rakieten N., Rakieten M.L., and Nadkarni M.R. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother. Rep. 29 (1963) 91-98
23. Serradas P., Bailbe D., Blondel O., and Portha B. Abnormal B-cell function in rats with non-insulin-dependent diabetes induced by neonatal streptozotocin: effect of in vivo insulin, phlorizin, or vanadate treatments. Pancreas 6 (1991) 54-62
24. Surwit R.S., Feinglos M.N., Livingston E.G., Kuhn C.M., and McCubbin J.A. Behavioral manipulation of the diabetic phenotype in ob/ob mice. Diabetes 33 (1984) 616-618
25. Surwit R.S., Kuhn C.M., Cochrane C., McCubbin J.A., and Feinglos M.N. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37 (1988) 1163-1167
26. Tanaka M., Misawa E., Ito Y., Habara N., Nomaguchi K., Yamada M., Toida T., Hayasawa H., Takase M., Inagaki M., and Higuchi R. Identification of five phytosterols from Aloe vera gel as anti-diabetic compounds. Biol. Pharm. Bull. 29 (2006) 1418-1422
27. Wencel H.E., Smothers C., Opara E.C., Kuhn C.M., Feinglos M.N., and Surwit R.S. Impaired second phase insulin response of diabetes-prone C57BL/6J mouse islets. Physiol. Behav. 57 (1995) 1215-1220
28. Wilson G.L., Patton N.J., McCord J.M., Mullins D.W., and Mossman B.T. Mechanisms of streptozotocin- and alloxan-induced damage in rat B cells. Diabetologia 27 (1984) 587-591
29. Yongchaiyudha S., Rungpitarangsi V., Bunyapraphatsara N., and Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice. I. Clinical trial in new cases of diabetes mellitus. Phytomedicine 3 (1996) 241-243
30. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787